GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer

Mise à jour : Il y a 5 ans
Référence : NCT00358566

Femme et Homme

Extrait

To investigate the efficacy of GV1001 in sequential combination with gemcitabine in locally advanced and metastatic adenocarcinoma of the pancreas.


Critère d'inclusion

  • Advanced Unresectable Pancreatic Cancer


Liens